Luc De Waal
About Luc De Waal
Luc De Waal is a Research Scientist II at the Broad Institute of MIT and Harvard, where he has worked since 2019. He has extensive experience in drug discovery and therapeutic development, with a strong academic background in biomedical science and cancer research.
Work at Broad Institute
Luc De Waal has been employed at the Broad Institute of MIT and Harvard as a Research Scientist II since 2019. His role involves engaging in collaborative research efforts aimed at advancing drug discovery. He has contributed to interdisciplinary research projects that integrate biotechnology with drug discovery, focusing on developing novel therapeutics to improve patient outcomes.
Previous Experience in Research
Prior to his current position, Luc De Waal worked at C4 Therapeutics, Inc. in various capacities. He served as a Research Scientist I in Chemical Biology for 7 months and in Proteomics and UPS Biology for 9 months. He also held the position of Research Scientist I in Drug Discovery Biology for 1 year. Additionally, he was a PhD Candidate at Dana-Farber Cancer Institute from 2011 to 2016, where he focused on cancer research.
Educational Background
Luc De Waal completed his Bachelor of Science (BSc) in Biomedical Science at Universiteit Utrecht from 2005 to 2008. He further pursued his education at the same institution, obtaining a Master of Science (MSc) in Cancer Genomics and Developmental Biology from 2008 to 2011. He earned his Doctor of Philosophy (Ph.D.) in Cancer Stem Cells & Developmental Biology from 2011 to 2016.
Early Career and Academic Involvement
Luc De Waal began his academic journey at Universiteit Utrecht, where he was an Undergraduate Student from 2005 to 2008. He also gained research experience as a Graduate Research Assistant at the Broad Institute for 6 months in 2009 to 2010. His early career laid the foundation for his subsequent roles in research and development within the field of biomedical science.